These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 25616467

  • 1. Burden of epilepsy: a prevalence-based cost of illness study of direct, indirect and intangible costs for epilepsy.
    Gao L, Xia L, Pan SQ, Xiong T, Li SC.
    Epilepsy Res; 2015 Feb; 110():146-56. PubMed ID: 25616467
    [Abstract] [Full Text] [Related]

  • 2. Burden of rheumatoid arthritis from a societal perspective: A prevalence-based study on cost of this illness for patients in China.
    Hu H, Luan L, Yang K, Li SC.
    Int J Rheum Dis; 2018 Aug; 21(8):1572-1580. PubMed ID: 28211251
    [Abstract] [Full Text] [Related]

  • 3. Direct and indirect costs of refractory epilepsy in a tertiary epilepsy center in Germany.
    Hamer HM, Spottke A, Aletsee C, Knake S, Reis J, Strzelczyk A, Oertel WH, Rosenow F, Dodel R.
    Epilepsia; 2006 Dec; 47(12):2165-72. PubMed ID: 17201718
    [Abstract] [Full Text] [Related]

  • 4. [Survey of adults living with epilepsy in Hungary: health-related quality of life and costs].
    Péntek M, Bereczki D, Gulácsi L, Mikudina B, Arányi Z, Juhos V, Baji P, Brodszky V.
    Ideggyogy Sz; 2013 Jul 30; 66(7-8):251-61. PubMed ID: 23971356
    [Abstract] [Full Text] [Related]

  • 5. Economic burden of epilepsy in a developing country: a retrospective cost analysis in China.
    Hong Z, Qu B, Wu XT, Yang TH, Zhang Q, Zhou D.
    Epilepsia; 2009 Oct 30; 50(10):2192-8. PubMed ID: 19583782
    [Abstract] [Full Text] [Related]

  • 6. Economic burden of schizophrenia: empirical analyses from a survey in Thailand.
    Phanthunane P, Whiteford H, Vos T, Bertram M.
    J Ment Health Policy Econ; 2012 Mar 30; 15(1):25-32. PubMed ID: 22611090
    [Abstract] [Full Text] [Related]

  • 7. [Financial burden of hepatitis B-related diseases and factors influencing the costs in Shenzhen, China].
    Liang S, Zhang SX, Ma QS, Xiao HW, Lü QY, Xie X, Mei SJ, Hu DS, Zhou BP, Li B, Chen JF, Cui FQ, Wang FZ, Liang XF.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Dec 30; 31(12):1340-5. PubMed ID: 21223660
    [Abstract] [Full Text] [Related]

  • 8. Quality of life and economic impact of refractory epilepsy in Spain: the ESPERA study.
    Villanueva V, Girón JM, Martín J, Hernández-Pastor LJ, Lahuerta J, Doz M, Cuesta M, Lévy-Bachelot L, Investigadores del estudio ESPERA.
    Neurologia; 2013 May 30; 28(4):195-204. PubMed ID: 22743210
    [Abstract] [Full Text] [Related]

  • 9. [Estimation on the intangible cost and influencing factors for patients with hepatitis B-related diseases].
    Ma QS, Zou YH, Zhang SX, Liang S, Xiao HW, Xie X, Mei SJ, Jia WD, Zhang YF, Cui FQ, Wang FZ, Liang XF.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2011 Aug 30; 32(8):764-7. PubMed ID: 22093463
    [Abstract] [Full Text] [Related]

  • 10. Costs of epilepsy and cost-driving factors in children, adolescents, and their caregivers in Germany.
    Riechmann J, Strzelczyk A, Reese JP, Boor R, Stephani U, Langner C, Neubauer BA, Oberman B, Philippi H, Rochel M, Seeger J, Seipelt P, Oertel WH, Dodel R, Rosenow F, Hamer HM, EpiPaed Study Group.
    Epilepsia; 2015 Sep 30; 56(9):1388-97. PubMed ID: 26235849
    [Abstract] [Full Text] [Related]

  • 11. Societal costs of rheumatoid arthritis in China: a hospital-based cross-sectional study.
    Xu C, Wang X, Mu R, Yang L, Zhang Y, Han S, Li X, Wang Y, Wang G, Zhu P, Jin H, Sun L, Chen H, Cui L, Zhang Z, Li Z, Li J, Zhang F, Lin J, Liu X, Hu S, Yang X, Lai B, Li X, Wang X, Su Y, Li Z.
    Arthritis Care Res (Hoboken); 2014 Apr 30; 66(4):523-31. PubMed ID: 24023001
    [Abstract] [Full Text] [Related]

  • 12. Analysis of direct, indirect, and intangible costs of epilepsy.
    Pato Pato A, Cebrián Pérez E, Cimas Hernando I, Lorenzo González JR, Rodríguez Constenla I, Gude Sampedro F.
    Neurologia; 2011 Apr 30; 26(1):32-8. PubMed ID: 21163205
    [Abstract] [Full Text] [Related]

  • 13. Cost of epilepsy care in a Nigerian tertiary hospital.
    Sanya EO, Kolo PM, Adekeye A, Mustapha K, Ademiluyi BA, Ajayi K.
    Niger Postgrad Med J; 2013 Sep 30; 20(3):218-22. PubMed ID: 24287754
    [Abstract] [Full Text] [Related]

  • 14. The economic burden of hypertension in rural south-west China.
    Le C, Zhankun S, Jun D, Keying Z.
    Trop Med Int Health; 2012 Dec 30; 17(12):1544-51. PubMed ID: 22973901
    [Abstract] [Full Text] [Related]

  • 15. Cost of epilepsy care in a Nigerian tertiary hospital.
    Sanya EO, Kolo PM, Adekeye A, Mustapha K, Ademiluyi BA, Ajayi K.
    Niger Postgrad Med J; 2013 Dec 30; 20(4):266-71. PubMed ID: 24633267
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of costs of epilepsy using an electronic practice management software in Germany.
    Noda AH, Hermsen A, Berkenfeld R, Dennig D, Endrass G, Kaltofen J, Safavi A, Wiehler S, Carl G, Meier U, Elger CE, Menzler K, Knake S, Rosenow F, Strzelczyk A.
    Seizure; 2015 Mar 30; 26():49-55. PubMed ID: 25799902
    [Abstract] [Full Text] [Related]

  • 17. A prospective study of direct medical costs in a large cohort of consecutively enrolled patients with refractory epilepsy in Italy.
    Luoni C, Canevini MP, Capovilla G, De Sarro G, Galimberti CA, Gatti G, Guerrini R, La Neve A, Mazzucchelli I, Rosati E, Specchio LM, Striano S, Tinuper P, Perucca E.
    Epilepsia; 2015 Jul 30; 56(7):1162-73. PubMed ID: 26046371
    [Abstract] [Full Text] [Related]

  • 18. Economic burden of specific learning disability: A prevalence-based cost of illness study of its direct, indirect, and intangible costs.
    Karande S, D'souza S, Gogtay N, Shiledar M, Sholapurwala R.
    J Postgrad Med; 2019 Jul 30; 65(3):152-159. PubMed ID: 31169134
    [Abstract] [Full Text] [Related]

  • 19. Direct medical costs and their predictors in patients with rheumatoid arthritis: a three-year study of 7,527 patients.
    Michaud K, Messer J, Choi HK, Wolfe F.
    Arthritis Rheum; 2003 Oct 30; 48(10):2750-62. PubMed ID: 14558079
    [Abstract] [Full Text] [Related]

  • 20. Trends in resource utilization and prescription of anticonvulsants for patients with active epilepsy in Germany.
    Strzelczyk A, Haag A, Reese JP, Nickolay T, Oertel WH, Dodel R, Knake S, Rosenow F, Hamer HM.
    Epilepsy Behav; 2013 Jun 30; 27(3):433-8. PubMed ID: 23591262
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.